Westover Capital Advisors LLC Lowers Stake in UnitedHealth Group Incorporated $UNH

Westover Capital Advisors LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 61.6% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 2,457 shares of the healthcare conglomerate’s stock after selling 3,944 shares during the period. Westover Capital Advisors LLC’s holdings in UnitedHealth Group were worth $767,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Chiron Capital Management LLC raised its stake in shares of UnitedHealth Group by 902.4% during the second quarter. Chiron Capital Management LLC now owns 4,140 shares of the healthcare conglomerate’s stock worth $1,292,000 after purchasing an additional 3,727 shares during the last quarter. Dorsey & Whitney Trust CO LLC raised its position in UnitedHealth Group by 2.0% during the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 46,539 shares of the healthcare conglomerate’s stock worth $14,519,000 after buying an additional 907 shares during the last quarter. Bulltick Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 200.8% in the 2nd quarter. Bulltick Wealth Management LLC now owns 23,945 shares of the healthcare conglomerate’s stock worth $7,470,000 after acquiring an additional 15,985 shares during the period. Rothschild Investment LLC increased its stake in shares of UnitedHealth Group by 85.0% during the second quarter. Rothschild Investment LLC now owns 10,878 shares of the healthcare conglomerate’s stock worth $3,394,000 after acquiring an additional 4,999 shares during the period. Finally, Raiffeisen Bank International AG lifted its position in UnitedHealth Group by 10.7% in the second quarter. Raiffeisen Bank International AG now owns 71,751 shares of the healthcare conglomerate’s stock valued at $21,671,000 after purchasing an additional 6,938 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Truist Financial raised their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a report on Tuesday, September 9th. TD Cowen raised their target price on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a report on Thursday, October 30th. Leerink Partners set a $410.00 price target on shares of UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Finally, Piper Sandler reduced their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research report on Tuesday, October 28th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Stock Down 0.4%

Shares of NYSE UNH opened at $320.59 on Tuesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The firm’s 50-day moving average is $347.66 and its two-hundred day moving average is $318.23. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83. The company has a market capitalization of $290.40 billion, a PE ratio of 16.73, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.15 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.